SEARCH RESULTS FOR: 得克萨斯A(3703490 results)
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Painless, disposable and sterile, AcuBEST acupuncture needles are made of high quality surgical stainless steel with spiral-wound handles. These single-use needles are engineered to be sharp for a smooth insertion. One needle with one (insertion) guide tube per sterile, individually sealed blister package. Box of 100 needles. 0.50mm x 75mm (22# x 3.0").
A & A MEDICAL SUPPLIES INC.
A1-22-300
In Commercial Distribution
- B465A1223001 ()
- B465A1223000 ()
- Needle Size 0.50mm x 75mm
- Acupuncture needle, single-use
Painless, disposable and sterile, AcuBEST acupuncture needles are made of high quality surgical stainless steel with spiral-wound handles. These single-use needles are engineered to be sharp for a smooth insertion. One needle with one (insertion) guide tube per sterile, individually sealed blister package. Box of 100 needles. 0.50mm x 50mm (22# x 2.0").
A & A MEDICAL SUPPLIES INC.
A1-22-200
In Commercial Distribution
- B465A1222001 ()
- B465A1222000 ()
- Needle Size 0.50mm x 50mm
- Acupuncture needle, single-use
Painless, disposable and sterile, AcuBEST acupuncture needles are made of high quality surgical stainless steel with spiral-wound handles. These single-use needles are engineered to be sharp for a smooth insertion. One needle with one (insertion) guide tube per sterile, individually sealed blister package. Box of 100 needles. 0.50mm x 40mm (22# x 1.5").
A & A MEDICAL SUPPLIES INC.
A1-22-150
In Commercial Distribution
- B465A1221501 ()
- B465A1221500 ()
- Needle Size 0.50mm x 40mm
- Acupuncture needle, single-use
The Alethia™ Group A Streptococcus (Group A Strep) assay, performed on the Alethia™ Instrument, is a qualitative in vitro diagnostic test for the detection of Streptococcus pyogenes (Group A beta-hemolytic Streptococcus) in throat swab specimens. The Alethia™ Group A Strep assay utilizes loop-mediated isothermal DNA amplification (LAMP) technology to detect Streptococcus pyogenes by targeting a segment of the Streptococcus pyogenes genome. Results from the Alethia™ Group A Strep assay can be used as an aid in the diagnosis of Group A Streptococcal pharyngitis. The assay is not intended to monitor treatment for Group A Streptococcus infections.
MERIDIAN BIOSCIENCE, INC.
480150
In Commercial Distribution
- 00840733102264 ()
480150
- Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
The Alethia™ Group A Streptococcus (Group A Strep) External Control Kit contains Positive Reagent for use with the Alethia™ Group A Streptococcus DNA Amplification Assay. The External Positive Control Reagent is used in conjunction with the Alethia™ Sample Preparation Apparatus II/Negative Control III reagent provided with the Group A Strep Kit as part of routine Quality Control Testing. External controls are used as part of a routine quality control program.
MERIDIAN BIOSCIENCE, INC.
479910
In Commercial Distribution
- 00840733102127 ()
479910
- Streptococcus mutans group antigen IVD, calibrator
The illumigene Group A Streptococcus (Group A Strep) assay, performed on the illumipro-10, is a qualitative in vitro diagnostic test for the detection of Streptococcus pyogenes (Group A beta-hemolytic Streptococcus) in throat swab specimens.
The illumigene Group A Strep assay utilizes loop-mediated isothermal DNA amplification (LAMP) technology to detect Streptococcus pyogenes by targeting a segment of the Streptococcus pyogenes genome. Results from the illumigene Group A Strep assay can be used as an aid in the diagnosis of Group A Streptococcal pharyngitis. The assay is not intended to monitor treatment for Group A Streptococcus infections.
MERIDIAN BIOSCIENCE, INC.
280150
Not in Commercial Distribution
- 00840733101335 ()
280150
- Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
The Nano-Check™ Influenza+COVID-19 Dual Test is a lateral flow immunochromatographic assay intended for in vitro rapid, simultaneous qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly from anterior nasal swab specimens of individuals with signs and symptoms of respiratory infection consistent with COVID-19 within the first five (5) days of symptom onset when tested at least twice over three days with at least 48 hours between tests. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. The Nano-Check™ Influenza+COVID-19 Dual Test is only for in vitro diagnostic use under the Food and Drug Administration’s Emergency Use Authorization. This product has not been cleared or approved.
NANO-DITECH CORPORATION
MD8151E
In Commercial Distribution
- 10895160002844 ()
- 00895160002847 ()
- Multiple-genus respiratory virus antigen IVD, kit, rapid ICT, clinical
ViraDx™ SARS-CoV-2/Flu A+B Rapid Antigen Test Kit, 25 tests
Lumos Diagnostics, Inc.
CP0031
In Commercial Distribution
- 00850056728706 ()
CP0031
- SARS-CoV-2 antigen IVD, kit, rapid ICT, clinical
- Influenza A/B virus antigen IVD, kit, rapid ICT, clinical
No Description
THE BINDING SITE GROUP LIMITED
NK626.T.A
In Commercial Distribution
- 05051700017008 ()
- Total immunoglobulin M (IgM total) IVD, kit, nephelometry/turbidimetry
No Description
THE BINDING SITE GROUP LIMITED
NK625.T.A
In Commercial Distribution
- 05051700016995 ()
- Total immunoglobulin M (IgM total) IVD, kit, nephelometry/turbidimetry